SYGNIS AG Signs Supply Agreement with US Biological for the Lightning-Link Antibody Labelling Technology

News   Nov 28, 2017

 
SYGNIS AG Signs Supply Agreement with US Biological for the Lightning-Link Antibody Labelling Technology
 
 
 

RELATED ARTICLES

PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug Discovery

News

Investment to fund expansion of operations and progression of drug target pipeline.

READ MORE

Using Diamonds to Create Drug Discovery Tools

News

Team led by Berkeley Lab and UC Berkeley researchers exploits tiny defects in diamonds to pave the way for enhanced biological imaging and drug studies

READ MORE

Hormone-Disrupting Environmental Chemicals May be Making Us Fat

News

Everyday products carry environmental chemicals that may be making us fat by interfering with our hormones, according to new research. Following recommendations on how to avoid these chemicals could help minimise exposure and potentially reduce the risk of obesity and its complications.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Applied Sciences Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE